Vandetanib to Treat Advanced Kidney Cancer

Clinical trial NCT01372813 · TERMINATED

Trial details

NCT number: NCT01372813
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Carcinoma

Start date: 2007-12-01
Primary completion: 2010-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.